세브란스병원

What 세브란스병원 does

Severance Hospital (세브란스병원) is the flagship tertiary general hospital of Yonsei University Health System (연세대학교 의료원), tracing its origins to Jejungwon, established in 1885 as Korea's first Western-style medical institution. The hospital operates a multi-site network anchored by its Seodaemun-gu (Seoul) headquarters, Gangnam Severance Hospital (including a cancer hospital, dental hospital, rehabilitation, and ophthalmology centers), and Yongin Severance Hospital in Gyeonggi Province. Its core service lines include outpatient care, inpatient treatment, surgery, health screening, and oncology, delivered direct-to-consumer through online appointment systems, telephone booking (1599-1004, 1588-7757), and physician referrals.

Severance operates Korea's first and only carbon ion (heavy ion) therapy center, anchored by a ~9,960-pyeong underground facility housing one fixed-type treatment room (operational since April 2023) and two rotation-type (360-degree gantry) treatment rooms (the first launched in May 2024), with full three-room operation targeted for 2027 and a planned capacity of approximately 900 patients annually. The center uses carbon ions accelerated to roughly 70% of the speed of light to deliver Bragg-peak dose distributions that concentrate therapeutic radiation on the tumor while minimizing damage to surrounding healthy tissue, typically in 4–12 fractions versus ~25 fractions for conventional radiotherapy. Underlying technology also includes the internally developed u-Severance 3.0 Electronic Medical Record system (covering EMR, OCS, and a Clinical Data Warehouse with both product and usage certifications through June 2026) and a hospital-wide ISMS information security certification valid through March 2027.

The business model is built on fee-for-service revenue from medical services (outpatient, inpatient, surgery, health screening via 1588-7757), non-covered services such as heavy ion therapy (priced per treatment plan, typically 4–12 sessions), and ancillary services including online issuance of medical records and certificates. Patients span individual consumers, the medically underserved (inoperable cancers, elderly patients unable to undergo surgery), and referred cases from the broader medical community. Severance's brand equity is reinforced by sustained #1 rankings in Korea's National Customer Satisfaction Index (15 consecutive years) and Korean Consumer Satisfaction Index (19 consecutive years), and selection in Newsweek's World's Best Hospitals.

Name

세브란스병원

Legal name

YONSEI CANCER CENTER

Website

https://cancer.severance.healthcare

Company type

Private

Founded year

1885

Operating status

Operating

Headcount range

101–250 employees

Short description

Severance Hospital (세브란스병원) is a flagship tertiary academic hospital under Yonsei University Health System serving patients across Seoul and Gyeonggi Province. It operates Korea's first and only carbon ion (heavy ion) therapy center alongside comprehensive outpatient, inpatient, surgical, and health screening services.

Ownership category

akta.pro rank

Product category

Tertiary Hospital Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Hospital healthcare services
• Cancer treatment
• Heavy ion therapy
• Radiation oncology
• Health screening

Headquarters

HQ city

Seoul (Seodaemun-gu)

HQ country

South Korea

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. 의료 서비스 수입(진료·수술·입원): 외래 진료, 수술, 입원 치료 등 의료 서비스 행위에 따른 수납으로 수익을 창출하는 전통적 의료 기관 모델.
2. 건강검진 서비스: 건강검진 예약(1588-7757)을 통해 건강검진 서비스를 제공하며 검진 수입을 창출.
3. 비급여 의료 서비스(중입자 치료 등): 중입자치료 등 비급여 진료 서비스에 대한 비용 수납. 중입자치료는 암종별 치료계획에 따라 4~12회 조사 이루어지며, 비급여 진료비 조회 페이지에서 확인 가능.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Severance Hospital is a private tertiary university hospital that delivers direct medical services to patients, including outpatient consultations, inpatient treatment, surgery, chemotherapy, radiation therapy, and comprehensive health screening. It is the home of Korea's first heavy ion (carbon ion) therapy center, offering precision radiotherapy for cancers such as pancreatic, liver, lung and prostate cancer using both fixed and rotating beam delivery systems. The hospital supports its care delivery through an integrated electronic medical record platform (u-Severance 3.0), online appointment booking, and online issuance of medical documents.

Product overview

세브란스병원은 연세대학교 의료원의 flagship 종합병원으로, 연세암병원, 심장혈관병원, 어린이병원, 안과병원, 재활병원 등 전문병원군과 강남세브란스병원, 용인세브란스병원 등 지역 병원网络中 운영된다. 주요 의료 서비스로는 중입자치료(세계 16번째, 국내 최초 도입), u-Severance 3.0 전자의무기록시스템, 온라인 진료 예약, 건강검진, 의무기록 온라인 발급 등이 있으며, 특히 연세암병원은 1969년 국내 최초 암센터로 설립되어 다양한 암종에 대한 통합적 치료를 제공한다.

Differentiator

Problem solved

Functional benefit

Brands

• 중입자치료센터 (Heavy Ion Therapy Center): Korea's first heavy ion therapy center using carbon ion radiotherapy for cancer treatment, featuring both fixed and rotating beam delivery systems.
• 회전형 중입자 치료기 (Rotating Heavy Ion Therapy)

Products and services

• Outpatient medical services (외래 진료)

Quantifiable outcome

• 수술 불가능한 췌장암 환자의 2년 국소제어율 80%(항암치료 + 중입자치료 병행 시, 일본 QST 연구 기준)
• +2 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• 일본 방사선의학종합연구소(QST NIRS)coreStrategic or Co-development Partner연세암병원은 일본 중입자치료의 중심인 방사선의학종합연구소(QST NIRS)를 포함한 다수의 해외 중입자치료센터와 교류하고 협력관계를 구축하고 있다. 이를 통해 최신 중입자치료에 대한 임상 교육 및 연구 환경을 제공하며, 중입자치료의 Global Standard 달성을 목표로 지속적인 협력 관계를 유지한다.

Scale indicators7 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• QST Hospital (National Institutes for Quantum Science and Technology): Japan's leading heavy ion therapy hospital and research center, established partner of Yonsei. Directly comparable as a heavy ion therapy operator and clinical research partner, and a global benchmark for carbon ion protocols that informs Severance's clinical practice.
• National Cancer Center Korea: Government-designated national cancer specialty center in Korea. Directly comparable as a dedicated cancer hospital focused on oncology treatment and research, competing for the same complex cancer referral pool as Yonsei Cancer Center.
• Samsung Medical Center: Another of the "Big 5" Korean academic medical centers in Seoul. Comparable as a competing cancer treatment destination with proton therapy, similar brand reputation, and similar patient demographic of complex oncology cases referred across Korea.
• Seoul National University Hospital: Korea's premier national university hospital and another top-tier academic medical center in Seoul. Comparable as a publicly-affiliated academic medical center competing for the same complex cancer patient pool, with strong research reputation and government-backed cancer programs.
• Asan Medical Center: Korea's largest hospital and a top-tier academic medical center in Seoul. Comparable as a Korean university-affiliated tertiary/quaternary care provider competing for complex cancer patients, with proton therapy capabilities that compete directly with Severance's heavy ion service.

Broad incumbents

• MD Anderson Cancer Center: World-leading US cancer specialty hospital and research center. Comparable as a global benchmark for cancer specialty hospital operations, clinical excellence, and patient outcomes, though operating at vastly larger scale and with broader modality portfolio.
• Memorial Sloan Kettering Cancer Center: Premier US cancer specialty hospital with global reputation. Comparable as a leading cancer specialty hospital competing for international medical tourism and complex oncology referrals, particularly relevant given Severance's premium positioning.

Emerging players

• Heidelberg University Hospital (HIT): Operates the Heidelberg Ion-Beam Therapy Center (HIT) in Germany, a pioneering European heavy ion facility. Comparable as a heavy ion therapy operator serving complex oncology cases with similar technology, though geographically separate and serving European patients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/iSEVERANCE
• YouTubeyoutube.com/user/SeveranceHospital
• Facebookfacebook.com/SeveranceFan
• Instagraminstagram.com/severance_insta
• LinkedInlinkedin.com/company/%EC%84%B8%EB%B8%8C%EB%9E%80%EC%8A%A4%EB%B3%91%EC%9B%90

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 세브란스병원